Sunshine Biopharma

QC - VarennesPharmaceutical2 H-1B visas (FY2023)

Website LinkedIn

Focus: Small Molecules

Sunshine Biopharma is a life sciences company focused on Small Molecules.

Cardiovascular Infectious Diseases Neurology Respiratory

Profile data last refreshed 2d ago

Open Jobs

Data completeness

2/9 — Limited

Company HealthSolid

Pipeline

Early-stage

50 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Products & Portfolio (22)

9 discontinued, 10 duplicate formulations not shown

Key Products by Revenue

unclear. However, the efficacy of aripiprazole in the listed indications could be mediated through a combination of partial agonist activity at D 2 and 5-HT 1A receptors and antagonist activity at 5-HT 2A receptors.

Help build intelligence for Sunshine Biopharma

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Pipeline & Clinical Trials

Motor-cognitive interactive robot

Stroke

N/A

Clinical Trials (1)

NCT06876597Motor-Cognitive Interactive Upper Limb Robot Rehabilitation for Post-Stroke Motor Dysfunction

N/A

Intrathecal morphine as well as local anaesthetic in Blocks

Cesarean Section

N/A

Clinical Trials (1)

NCT03267628Comparison of Intrathecal Morphine With the Quadratus Lumborum Type 2 Block for Post-operative Analgesia Following Elective Caesarean Section (QLBvITM Study)

N/A

Online stimulation

Stroke

N/A

Clinical Trials (1)

NCT06752499rTMS Combined With Motor Training for the Treatment of Upper Limb Motor Dysfunction in Stroke Patients

N/A

active iTBS

Autism Spectrum Disorder

N/A

Clinical Trials (1)

NCT06950437pBFS Guided aiTBS Over Language Network for ASD Child

N/A

Pleurodesis via Video-assisted thoracoscopic surgery

Malignant Pleural Effusion

N/A

Clinical Trials (1)

NCT04322136AMPLE-3: IPC Plus Talc vs VATS in Management of Malignant Pleural Effusion

N/A

PROGRAM

Obesity

N/A

Clinical Trials (1)

NCT03097965Safety Evaluation of a Lifestyle Modification Program In.Form 1.1

N/A

Tele-monitored home exercise program

Total Knee Replacement

N/A

Clinical Trials (1)

NCT04352972Hospital-based Usual cAre Versus Tele-monitoring Rehabilitation

N/A

Power Line Program

Metabolic Health

N/A

Clinical Trials (1)

NCT06486077Metabolic Health 1: Power Line Evaluation; Effect Size Determination

N/A

Transperineal Ultrasound for Assessing and Predicting Response in Hospitalized Patients with a Flare

Ulcerative Colitis

N/A

Clinical Trials (1)

NCT06496516Transperineal Ultrasound for Assessing and Predicting Response in Hospitalized Patients with a Flare of Ulcerative Colitis

N/A

physiotherapeutic scoliosis specific exercises

Scoliosis Idiopathic Adolescent

N/A

Clinical Trials (1)

NCT02968043Efficacy of Physiotherapeutic Scoliosis Specific Exercises in Adolescent Idiopathic Scoliosis

N/A

Redefine

Obesity & Overweight

N/A

Clinical Trials (1)

NCT07447843Safety and Tolerability of a Nutritional Formula Designed to Aid in Maintenance of Muscle During Periods of Caloric Restriction in Adults

N/A

MINGO

X-Linked Dystonia Parkinsonism

N/A

Clinical Trials (1)

NCT03019458MINGO Supplemental Trial in X-linked Dystonia-Parkinsonism Patients

N/A

609A

Solid Tumors

N/A

Clinical Trials (1)

NCT03998345Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A in China

N/A

Understanding Allergies and Sensitizations in Healthy and Allergic Individuals

Allergy

N/A

Experimental

Cognitive Health

N/A

Clinical Trials (1)

NCT07018674Acute Cognitive Effects of Brain Edge

N/A

The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients

Thrombocytopenia

N/A

Clinical Trials (1)

NCT02344979The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLC

N/A

Prog: Purify-2

Gastrointestinal Symptoms

N/A

Clinical Trials (1)

NCT03685552Safety Evaluation of a Diet and Nutritional Supplementation Program- Purify 2.0

N/A

Rehearsal strategy

Autism

N/A

Clinical Trials (1)

NCT04209452Improving Working Memory of Children With Autism

N/A

Shanghai Clinical Cohort - Parkinson's Disease (Reserve)

Parkinson's Disease (PD)

N/A

Clinical Trials (1)

NCT07353463Shanghai Clinical Cohort - Parkinson's Disease (Reserve)

N/A

virtual reality

Stroke

N/A

Clinical Trials (1)

NCT06704074Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients

N/A

Atrioventricular nodal ablation

Atrial Fibrillation (AF)

N/A

Clinical Trials (1)

NCT07059208Atrioventricular Nodal Ablation Versus Pulmonary Vein Isolation - Patient Centred Decisions

N/A

PROG2

Obesity

N/A

Clinical Trials (1)

NCT03098056Safety and Tolerance of a Nutritional Intervention Program- In.Form 1.2

N/A

PVRI GoDeep Global Deep Phenotyping Meta-Registry for Pulmonary Hypertension

Pulmonary Hypertension

N/A

Avatar therapy

Auditory Hallucination

N/A

Clinical Trials (1)

NCT05982158Avatar-mediated Therapy Versus Cognitive Behavioural Therapy for Persisting Experiences of Hearing Voices

N/A

Litapiprant Tablet

Asthma

Phase 1

Clinical Trials (1)

NCT03663686The Safety, Tolerability and Pharmacokinetic Study of Litapiprant Tablets in Healthy Male and Female Subjects

Phase 1

SSS17

Anemia in Chronic Kidney Diseases

Phase 1

Clinical Trials (1)

NCT04893187A Phase 1 Study of SSS17 in Healthy Subjects.

Phase 1

CT053PTSA

Acute Myeloid Leukemia (AML)

Phase 1

Clinical Trials (1)

NCT03125876A Phase Ib Study of CT053PTSA in Relapsed / Refractory Acute Myeloid Leukemia (AML)

Phase 1

Liraglutide injection,RD12014

Type 2 Diabetes

Phase 1

Clinical Trials (1)

NCT05294536A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects

Phase 1

Clifutinib with fed state

Acute Myeloid Leukemia in Children

Phase 1

Clinical Trials (1)

NCT05454098Clifutinib Food Effect Study in Healthy Subjects

Phase 1

HEC74647PA capsule

Chronic Hepatitis C

Phase 1

Clinical Trials (1)

NCT04201275The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected Subjects

Phase 1

14028 injection

Type 2 Diabetes

Phase 1

Clinical Trials (1)

NCT05459285A Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY® in Healthy Chinese Subjects

Phase 1

HEC585

Idiopathic Pulmonary Fibrosis

Phase 1

Clinical Trials (1)

NCT05383131To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers

Phase 1

Humanized TNFα monoclonal antibody

Rheumatoid Arthritis

Phase 1

Clinical Trials (1)

NCT02460393A Trial With Humanized TNFα Monoclonal Antibody Injection by Single Dose and Dose Escalation in Healthy Subjects

Phase 1

610 30mg group

Asthma

Phase 1

Clinical Trials (1)

NCT05584306A Dose Ranging Placebo-controlled Double-blind Study to Evaluate the Safety, Pharmacokinetics and Efficacy of 610 in Participants With Severe Eosinophilic Asthma

Phase 1

Recombinant erythropoietin stimulating protein

Chronic Renal Failure

Phase 1

Clinical Trials (1)

NCT02356419rESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic Characteristics

Phase 1

HEC110114 tablet

Chronic Hepatitis C

Phase 1

Clinical Trials (1)

NCT03903081The Tolerability and Pharmacokinetics Study of HEC110114 Tablets in Healthy Adult Subjects

Phase 1

Clascoterone Cream 1%

Acne Vulgaris

Phase 1

Clinical Trials (1)

NCT06454708Pharmacokinetics, Safety and Tolerability of Clascoterone Cream 1% in Healthy Chinese Adult Subjects

Phase 1

HEC74647

Chronic Hepatitis C

Phase 1

Clinical Trials (1)

NCT04232514Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects

Phase 1

HEC73077 tablets

Diabetic Nephropathy

Phase 1

Clinical Trials (1)

NCT05492630Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy Subjects

Phase 1

Larotinib

Esophageal Cancer

Phase 1

Clinical Trials (1)

NCT05048368Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function

Phase 1

SSGJ-613

Systemic Juvenile Idiopathic Arthritis

Phase 1

Clinical Trials (1)

NCT05027373Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection

Phase 1

HEC585

Idiopathic Pulmonary Fibrosis

Phase 1

Clinical Trials (1)

NCT04512170Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects

Phase 1

GLS4

Chronic Hepatitis B

Phase 1

Clinical Trials (1)

NCT03662568A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects

Phase 1

yimitasvir

Chronic Hepatitis c

Phase 1

Clinical Trials (1)

NCT03462173The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults Subjects

Phase 1

Clifutinib Besylate

Acute Myeloid Leukemia

Phase 1

Clinical Trials (1)

NCT04827069A Clinical Trial to Evaluate Clifutinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia(AML)

Phase 1

HEC122505MsOH

Parkinson Disease

Phase 1

Clinical Trials (1)

NCT04625361Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC122505MsOH Tablets in Healthy Adult Subjects

Phase 1

HEC83518 tablets

Insomnia

Phase 1

Clinical Trials (1)

NCT04596007The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets in Chinses Healthy Subjects

Phase 1

CPGJ602

Metastatic Colorectal Cancer

Phase 1

Clinical Trials (1)

NCT03356158A Study of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Metastatic Colorectal Cancer

Phase 1

Insulin degludec injection, RD15003

Type 2 Diabetes

Phase 1

Clinical Trials (1)

NCT05576298A Clinical Study Comparing the Pharmacokinetics and Pharmacodynamic Characteristics of Insulin Degludec Injection (RD15003) and Insulin Degludec Injection (Tresiba®) in Healthy Subjects

Phase 1

SSS11

Gout

Phase 1

Clinical Trials (1)

NCT03388515A Study to Assess the Safety and Tolerability of SSS11 in Healthy Subjects.

Phase 1

Sunshine Biopharma

Products & Portfolio (22)

Key Products by Revenue

Other Products (21)

Pipeline & Clinical Trials

Open Jobs (0)

Visa Sponsorship